Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain?

In an era of dramatic discoveries in neuroscience and genetics, it is likely that many popular theories and formulations about mental illness will need to be revised, if not discarded. The “neurodevelopmental hypothesis” is one of the popular theories about the origins of schizophrenia, which posits that abnormalities of early brain development increase risk for the subsequent emergence of the clinical syndrome. 1-3 An early piece of evidence in support of this hypothesis was the apparent lack of progression of cerebral ventricular enlargement observed with computed tomography during illness. 4-9 An important assumption of the neurodevelopmental hypothesis is that the putative primary pathologic condition of the brain is a reflection of abnormalities of early development. The neurodevelopmental hypothesis thus assumes that developmental neuropathologic conditions should arrest early in life and not continue to progress. The computed tomography results showing no apparent progression seemed consistent with this assumption. However, a recent series of magnetic resonance imaging (MRI) studies has called into question this assumption, by revealing changes in measurements of brain structures over short periods in patients who have been ill for varying durations and at various stages of life. These recent studies 10-14 have generated enthusiasm for a “neurodegenerative hypothesis,” harkening back to proposals of Kraepelin and other neuropathologists during the first quarter of the 20th century that there is destruction of neural tissue associated with psychosis. In fact, results of MRI measurements have been cited as support for a much broader conceptual revolution in psychiatry, a “neurotoxicity hypothesis” for many psychiatric illnesses, including affective disorders 15,16 and anxiety and stress disorders 17-19 and even jet lag. 20 This recent trend has been bolstered by basic discoveries about the adaptability of neuronal connections 21 and the viability and reproducibility of neurons in the adult brain (eg, apoptosis and neurogenesis). 22,23 These developments have led some to opine that the neurodegenerative hypothesis of schizophrenia may have been unjustly overshadowed by the ascendancy of the neurodevelopmental hypothesis. 24

[1]  U. Klose,et al.  Reversible brain shrinkage in abstinent alcoholics, measured by MRI , 2004, Neuroradiology.

[2]  Kwangwook Cho,et al.  Chronic 'jet lag' produces temporal lobe atrophy and spatial cognitive deficits , 2001, Nature Neuroscience.

[3]  Leszek Kaczmarek,et al.  Kainate-induced genes in the hippocampus: lessons from expression patterns , 2001, Neurochemistry International.

[4]  D. Barber,et al.  Dexamethasone induces limited apoptosis and extensive sublethal damage to specific subregions of the striatum and hippocampus: implications for mood disorders , 2001, Neuroscience.

[5]  J. Lieberman,et al.  Longitudinal study of brain morphology in first episode schizophrenia , 2001, Biological Psychiatry.

[6]  K O Lim,et al.  Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. , 2001, Archives of general psychiatry.

[7]  R. Kahn,et al.  The Effect of Clozapine on Caudate Nucleus Volume in Schizophrenic Patients Previously Treated with Typical Antipsychotics , 2001, Neuropsychopharmacology.

[8]  P. J. Brooks Brain atrophy and neuronal loss in alcoholism: a role for DNA damage? , 2000, Neurochemistry International.

[9]  R. Sapolsky,et al.  The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death , 2000, Biological Psychiatry.

[10]  G. Moore,et al.  Lithium-induced increase in human brain grey matter , 2000, The Lancet.

[11]  J. Lieberman,et al.  Cortical Bcl-2 protein expression and apoptotic regulation in schizophrenia , 2000, Biological Psychiatry.

[12]  S Marenco,et al.  The neurodevelopmental hypothesis of schizophrenia: Following a trail of evidence from cradle to grave , 2000, Development and Psychopathology.

[13]  D. Garver,et al.  Brain and ventricle instability during psychotic episodes of the schizophrenias , 2000, Schizophrenia Research.

[14]  J. Hidalgo,et al.  Enhanced seizures and hippocampal neurodegeneration following kainic acid‐induced seizures in metallothionein‐I + II‐deficient mice , 2000, The European journal of neuroscience.

[15]  I Ferrer,et al.  N-myc and c-myc expression in Alzheimer disease, Huntington disease and Parkinson disease. , 2000, Brain research. Molecular brain research.

[16]  M. Keshavan,et al.  Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. , 2000, Archives of general psychiatry.

[17]  Y. Higami,et al.  Apoptosis in the aging process , 2000, Cell and Tissue Research.

[18]  Hilkka Soininen,et al.  Hippocampus in Alzheimer’s disease: a 3-year follow-up MRI study , 2000, Biological Psychiatry.

[19]  E. Denton,et al.  The identification of cerebral volume changes in treated growth hormone-deficient adults using serial 3D MR image processing. , 2000, Journal of computer assisted tomography.

[20]  C. Behl,et al.  Apoptosis and Alzheimer's disease , 2000, Journal of Neural Transmission.

[21]  L. Staib,et al.  Hippocampal volume reduction in major depression. , 2000, The American journal of psychiatry.

[22]  R. Nicoll,et al.  Long-term potentiation--a decade of progress? , 1999, Science.

[23]  Jeffrey A Lieberman,et al.  Is schizophrenia a neurodegenerative disorder? a clinical and neurobiological perspective , 1999, Biological Psychiatry.

[24]  Tyrone D. Cannon,et al.  A prospective cohort study of neurodevelopmental processes in the genesis and epigenesis of schizophrenia , 1999, Development and Psychopathology.

[25]  N C Andreasen,et al.  Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. , 1999, The American journal of psychiatry.

[26]  Frederick Andermann,et al.  Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy , 1999, Annals of neurology.

[27]  J. Douglas Bremner,et al.  Does stress damage the brain? , 1999, Biological Psychiatry.

[28]  Paul J. Harrison The neuropathology of schizophrenia , 2008 .

[29]  F. Gage,et al.  Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus , 1999, Nature Neuroscience.

[30]  D. Weinberger,et al.  Cell biology of the hippocampal formation in schizophrenia , 1999, Biological Psychiatry.

[31]  L. DeLisi,et al.  Association of brain structural change with the heterogeneous course of schizophrenia from early childhood through five years subsequent to a first hospitalization , 1998, Psychiatry Research: Neuroimaging.

[32]  B. Woods Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. , 1998, The American journal of psychiatry.

[33]  S. Cory,et al.  The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.

[34]  M. Berciano,et al.  Reactive gliosis of immature Bergmann glia and microglial cell activation in response to cell death of granule cell precursors induced by methylazoxymethanol treatment in developing rat cerebellum , 1998, Anatomy and Embryology.

[35]  Lina Shihabuddin,et al.  Ventricular Enlargement in Poor-Outcome Schizophrenia , 1998, Biological Psychiatry.

[36]  Bruce Mcewen,et al.  Stress, Adaptation, and Disease: Allostasis and Allostatic Load , 1998, Annals of the New York Academy of Sciences.

[37]  J N Giedd,et al.  Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. , 1998, The American journal of psychiatry.

[38]  P. Goldman-Rakic,et al.  Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: Application of a three‐dimensional, stereologic counting method , 1998, The Journal of comparative neurology.

[39]  J. Trojanowski,et al.  Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. , 1998, Archives of general psychiatry.

[40]  Tyrone D. Cannon,et al.  A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. , 1998, Archives of general psychiatry.

[41]  B. Rund,et al.  A review of longitudinal studies of cognitive functions in schizophrenia patients. , 1998, Schizophrenia bulletin.

[42]  J L Rapoport,et al.  Childhood-Onset Schizophrenia: Progressive Ventricular Change During Adolescence , 1997 .

[43]  James D. Christensen,et al.  Progression of cerebroventricular enlargement and the subtyping of schizophrenia , 1997, Psychiatry Research: Neuroimaging.

[44]  L. DeLisi,et al.  Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia , 1997, Psychiatry Research: Neuroimaging.

[45]  E. Nestler,et al.  A molecular and cellular theory of depression. , 1997, Archives of general psychiatry.

[46]  F. Gage,et al.  More hippocampal neurons in adult mice living in an enriched environment , 1997, Nature.

[47]  Lynn E. DeLisi,et al.  Is schizophrenia a lifetime disorder of brain plasticity, growth and aging? , 1997, Schizophrenia Research.

[48]  N C Andreasen,et al.  Reversibility of brain tissue loss in anorexia nervosa assessed with a computerized Talairach 3-D proportional grid , 1996, Psychological Medicine.

[49]  J. Olney,et al.  Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.

[50]  K O Lim,et al.  Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics. , 1995, Alcoholism, clinical and experimental research.

[51]  L. DeLisi,et al.  A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: Preliminary findings , 1995, Biological Psychiatry.

[52]  J. Hajnal,et al.  Detection of Subtle Brain Changes Using Subvoxel Registration and Subtraction of Serial MR Images , 1995, Journal of computer assisted tomography.

[53]  C. Bieberich,et al.  The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice , 1995, Nature Genetics.

[54]  T. Goldberg,et al.  Cerebral ventricular enlargement in schizophreniform disorder does not progress A seven year follow-up study , 1994, Schizophrenia Research.

[55]  Y. Ben-Ari,et al.  Kainate-induced apoptotic cell death in hippocampal neurons , 1994, Neuroscience.

[56]  J. Lieberman,et al.  Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. , 1994, The American journal of psychiatry.

[57]  G. Freund Apoptosis and gene expression: perspectives on alcohol-induced brain damage. , 1994, Alcohol.

[58]  L. Kaczmarek,et al.  DNA fragmentation in rat brain after intraperitoneal administration of kainate , 1994, Neuroreport.

[59]  A. Vita,et al.  Stability of cerebral ventricular size from the appearance of the first psychotic symptoms to the later diagnosis of schizophrenia , 1994, Biological Psychiatry.

[60]  B. Pakkenberg,et al.  Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors , 1993, Biological Psychiatry.

[61]  P. Gloor,et al.  Atrophy of mesial structures in patients with temporal lobe epilepsy: Cause or consequence of repeated seizures? , 1993, Annals of neurology.

[62]  J. Olney,et al.  Neuronal Vacuolization and Necrosis Induced by the Noncompetitive N-methyl-d-aspartate (NMDA) Antagonist MK(+)801 (Dizocilpine Maleate): A Light and Electron Microscopic Evaluation of the Rat Retrosplenial Cortex , 1993, Experimental Neurology.

[63]  Clifford R. Jack,et al.  Quantitative MRI hippocampal volumes: association with onset and duration of epilepsy, and febrile convulsions in temporal lobectomy patients , 1993, Epilepsy Research.

[64]  L. DeLisi,et al.  Left ventricular enlargement associated with diagnostic outcome of schizophreniform disorder , 1992, Biological Psychiatry.

[65]  E. Turner,et al.  Three-year follow-up of older schizophrenics: Extrapyramidal syndromes, psychiatric symptoms, and ventricular brain ratio , 1991, Biological Psychiatry.

[66]  R. Sapolsky,et al.  Hippocampal damage associated with prolonged glucocorticoid exposure in primates , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[67]  B Horwitz,et al.  Critical analysis of the use of computer‐assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type , 1990, Neurology.

[68]  R. Miller Schizophrenia as a progressive disorder: Relations to EEG, CT. neuropathological and other evidence , 1989, Progress in Neurobiology.

[69]  S. Galderisi,et al.  Ventricle-to-brain ratio in schizophrenia: a controlled follow-up study , 1989, Biological Psychiatry.

[70]  A. Vita,et al.  Brain morphology in schizophrenia: a 2‐ to 5‐year CT scan follow‐up study , 1988, Acta psychiatrica Scandinavica.

[71]  D. Weinberger,et al.  Stability of CT scan findings in schizophrenia: results of an 8 year follow-up study. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[72]  D. Weinberger Implications of normal brain development for the pathogenesis of schizophrenia. , 1987, Archives of general psychiatry.

[73]  B. McEwen,et al.  Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[74]  Neil Gordon,et al.  Apparent Cerebral Atrophy in Patients on Treatment with Steroids , 1980, Developmental medicine and child neurology.